Arxis, Inc. Class A Common Stock
NASDAQ:ARXSAerospace & Defense
+$0.89 today
- Market cap
- $2.16B
- Beta
- 0.00
Volume 0.49M
Average 1.55M
ARXS Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Arxis, Inc. Class A Common StockNASDAQ: ARXS
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development of $0 in Q2 FY2026
Q2 FY2026 research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
Research & Development vs competitors
How ARXS compares with its peers on the latest reported figures
- ARXS's FY2025 research & development of $0 is the 8th highest of the 11 companies compared; the peer median is $30.77M.
- Research & development amounts to 0.0% of revenue for ARXS, versus a peer median of 3.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $98.16M | +5.7% | +5.6% | 2.7% | |
| LTM Oct 2026 | $62.6M | +0.2% | -18.1% | 6.2% | |
| LTM Oct 2026 | $42.86M | +30.5% | — | 4.3% | |
| LTM Jun 2026 | $42.36M | +621.2% | +58.7% | 9.9% | |
| LTM Sep 2026 | $32.31M | +7.6% | +5.3% | 0.8% | |
| LTM Mar 2026 | $29.24M | -23.6% | +0.2% | 5.2% | |
| LTM Mar 2026 | $25.71M | +11.9% | +1.6% | 4.6% | |
ARXSArxis, Inc. Class A Common Stock | FY2025 | $0 | — | — | 0.0% |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jul 2026 | $0 | — | — | 0.0% | |
AADXApplied Aerospace & Defense, Inc. | LTM Jun 2026 | $0 | — | — | 0.0% |
| Peer median (excluding ARXS) | $30.77M | +7.6% | +3.5% | 3.5% | |
Competitors are the stored peer set for ARXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2025 Dec 2025 |
|---|---|
| Revenue | 1.6B |
| Cost of Revenue | 843.02M |
| Gross Profit | 758.06M |
| Gross Margin | 47.3% |
| Research & Development | 0 |
| Selling, General & Admin | 509.53M |
| Operating Expenses | 650.15M |
| Depreciation & Amortization | 200.11M |
| EBITDA | 313.98M |
| EBITDA Margin | 19.6% |
| Operating Income | 107.91M |
| Operating Margin | 6.7% |
| Interest Income | 0 |
| Interest Expense | 178.51M |
| Other Income / Expenses | (172.55M) |
| Income Before Tax | (64.64M) |
| Pre-Tax Margin | -4.0% |
| Income Tax Expense | (14.81M) |
| Net Income | (49.83M) |
| Net Margin | -3.1% |
| EPS (Basic) | (0.12) |
| EPS (Diluted) | (0.12) |
| Weighted Avg Shares | 404.33M |
| Weighted Avg Shares (Diluted) | 404.33M |
Arxis, Inc. Class A Common Stock
NASDAQ:ARXS
Intrinsic Alpha fair value
Locked
Current Price
$53.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.